AI
TMDX icon

Axiom Investors’s Transmedics TMDX Stock Holding History

Axiom Investors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-99,478
Closed -$15.6M – 146
2024
Q3 		$15.6M Buy
99,478
+8,843
+10% +$1.36M 0.14% 73
2024
Q2 		$13.7M Buy
90,635
+18,790
+26% +$2.25M 0.12% 74
2024
Q1 		$5.31M Sell
71,845
-11,905
-14% -$981K 0.05% 106
2023
Q4 		$6.61M Buy
83,750
+38,029
+83% +$2.29M 0.06% 101
2023
Q3 		$2.5M Buy
45,721
+4,341
+10% +$312K 0.04% 92
2023
Q2 		$3.48M Buy
41,380
+23,530
+132% +$1.8M 0.05% 83
2023
Q1 		$1.35M Buy
+17,850
New +$1.23M 0.02% 116

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Axiom Investors's TMDX Position: Q4 2024 in Review

Axiom Investors sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 99,478 shares — an estimated $15.6M sold.

Axiom Investors first reported a position in TMDX in Q1 2023 and held it in 7 quarters. The position peaked at $15.6M in Q3 2024. 315 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

  • Axiom Investors reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
  • Axiom Investors sold 99,478 Transmedics shares in Q4 2024, an estimated $15.6M.
  • Axiom Investors first reported a position in Transmedics in Q1 2023 and held it in 7 quarters.
  • Axiom Investors's Transmedics position peaked at $15.6M in Q3 2024.
  • 315 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on Axiom Investors's 13F filing for Q4 2024, filed 12 Feb 2025.